Clinical Trial Update: A Study of CM310 in Subjects With Moderate to Severe Asthma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial of CM310 in moderate to severe asthma has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• CM310

Snippet

Sponsor: Keymed Biosciences Co.Ltd | Conditions: Asthma | Phase 2 | Status: COMPLETED